Ashton Thomas Private Wealth, LLC Ventyx Biosciences, Inc. Transaction History
Ashton Thomas Private Wealth, LLC
- $2.84 Trillion
- Q2 2025
A detailed history of Ashton Thomas Private Wealth, LLC transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Ashton Thomas Private Wealth, LLC holds 33,374 shares of VTYX stock, worth $93,780. This represents 0.0% of its overall portfolio holdings.
Number of Shares
33,374Holding current value
$93,780% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding VTYX
# of Institutions
125Shares Held
44.8MCall Options Held
35.2KPut Options Held
40.6K-
Black Rock Inc. New York, NY4.77MShares$13.4 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.23MShares$11.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$9.87 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$8.71 Million0.23% of portfolio
-
Sio Capital Management, LLC New York, NY2.58MShares$7.26 Million1.12% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $159M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...